Anticoagulants, vitamine K antagonists: Patient self-monitoring and self-management
DISEASE INTERVENTION COMPARISON RESULTS
Lancet. 2006 Feb 4;367(9508):404-11 Meta-Analysis
IN anticoagulants, vitamin K antagonists, monitoring The Use of
patient self-monitoring of anticoagulation
As Dosage Scheme
Is better Than
standard monitoring by a health professional
To reduce thromboembolic events (OR 0.45, NNT aprox 38), all-cause mortality (OR 0.61, NNT aprox 67), and major haemorrhage (OR 0.65, NNT aprox 67)
Ann Intern Med. 2011 Apr 5;154(7):472-82 Meta-Analysis
IN anticoagulants, vitamin K antagonists, monitoring The Use of
patient self-monitoring of anticoagulation, with or without self-management
As Dosage Scheme
Is better Than
usual care and monitoring by a health professional
To reduce thromboembolic events (OR 0.58) and total mortality (OR 0.74), with no excess of major bleedings (OR 0.89)